Edwards Lifesciences Corp. (EW): Price and Financial Metrics
EW Price/Volume Stats
Current price | $92.85 | 52-week high | $95.27 |
Prev. close | $92.31 | 52-week low | $60.57 |
Day low | $91.95 | Volume | 2,899,600 |
Day high | $93.04 | Avg. volume | 4,195,340 |
50-day MA | $82.98 | Dividend yield | N/A |
200-day MA | $78.39 | Market Cap | 55.83B |
EW Stock Price Chart Interactive Chart >
EW POWR Grades
- Quality is the dimension where EW ranks best; there it ranks ahead of 96.29% of US stocks.
- EW's strongest trending metric is Sentiment; it's been moving down over the last 26 weeks.
- EW ranks lowest in Sentiment; there it ranks in the 20th percentile.
EW Stock Summary
- EW has a market capitalization of $44,316,780,000 -- more than approximately 94.17% of US stocks.
- The price/operating cash flow metric for EDWARDS LIFESCIENCES CORP is higher than 91.44% of stocks in our set with a positive cash flow.
- With a price/sales ratio of 7.62, EDWARDS LIFESCIENCES CORP has a higher such ratio than 86.02% of stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to EDWARDS LIFESCIENCES CORP are DOW, DOX, GLW, CMI, and TRMB.
- Visit EW's SEC page to see the company's official filings. To visit the company's web site, go to www.edwards.com.
EW Valuation Summary
- In comparison to the median Healthcare stock, EW's EV/EBIT ratio is 89.04% higher, now standing at 27.6.
- Over the past 243 months, EW's price/sales ratio has gone up 5.8.
Below are key valuation metrics over time for EW.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
EW | 2023-12-29 | 7.9 | 6.9 | 32.3 | 27.6 |
EW | 2023-12-28 | 8.0 | 7.0 | 32.5 | 27.7 |
EW | 2023-12-27 | 7.9 | 6.9 | 32.3 | 27.6 |
EW | 2023-12-26 | 7.9 | 6.9 | 32.3 | 27.6 |
EW | 2023-12-22 | 7.9 | 6.9 | 32.1 | 27.4 |
EW | 2023-12-21 | 7.8 | 6.8 | 31.7 | 27.1 |
EW Growth Metrics
- Its 4 year net cashflow from operations growth rate is now at 90.86%.
- Its 5 year revenue growth rate is now at 42.34%.
- Its 2 year revenue growth rate is now at 19.48%.
The table below shows EW's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-12-31 | 5,382.4 | 1,218.2 | 1,521.9 |
2022-09-30 | 5,363.8 | 1,309 | 1,458.8 |
2022-06-30 | 5,355 | 1,531 | 1,455.4 |
2022-03-31 | 5,357.1 | 1,724.9 | 1,538.5 |
2021-12-31 | 5,232.5 | 1,732.1 | 1,503.1 |
2021-09-30 | 5,094.5 | 1,758.5 | 1,477.3 |
EW's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- EW has a Quality Grade of B, ranking ahead of 92.8% of graded US stocks.
- EW's asset turnover comes in at 0.681 -- ranking 53rd of 186 Medical Equipment stocks.
- ATRS, SRDX, and ANGO are the stocks whose asset turnover ratios are most correlated with EW.
The table below shows EW's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 0.681 | 0.755 | 0.381 |
2021-03-31 | 0.647 | 0.752 | 0.229 |
2020-12-31 | 0.661 | 0.754 | 0.231 |
2020-09-30 | 0.678 | 0.755 | 0.235 |
2020-06-30 | 0.693 | 0.750 | 0.233 |
2020-03-31 | 0.744 | 0.744 | 0.370 |
EW Price Target
For more insight on analysts targets of EW, see our EW price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $119.36 | Average Broker Recommendation | 1.62 (Moderate Buy) |
Edwards Lifesciences Corp. (EW) Company Bio
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; the Dominican Republic; Puerto Rico; and Singapore; and is building a new facility due to be completed in 2021 in Limerick, Ireland. (Source:Wikipedia)
Latest EW News From Around the Web
Below are the latest news stories about EDWARDS LIFESCIENCES CORP that investors may wish to consider to help them evaluate EW as an investment opportunity.
Fears Of Negative Clinical Trial Result Dragged Edwards Lifesciences Corporation (EW) in Q3Scout Investments, Inc, an affiliate of Carillon Tower Advisers, Inc, released the “Carillon Scout Mid Cap Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. Major equity indices began the quarter on a positive note, but as the quarter progressed, they succumbed to increased interest rates and economic concerns. Large caps […] |
ITGR or EW: Which Is the Better Value Stock Right Now?ITGR vs. EW: Which Stock Is the Better Value Option? |
Some Confidence Is Lacking In Edwards Lifesciences Corporation's (NYSE:EW) P/EWith a price-to-earnings (or "P/E") ratio of 32.6x Edwards Lifesciences Corporation ( NYSE:EW ) may be sending very... |
Edwards Lifesciences (EW) Forwards Growth Strategy and OutlookEdwards Lifesciences' (EW) TAVR remains strong, driven by greater awareness, patient activation and advances in new technologies such as RESILIA. |
Edwards to spin off its critical care businessEdwards is the latest healthcare firm to spin off a business to focus on specific markets, following larger companies like Johnson & Johnson and GE. |
EW Price Returns
1-mo | 7.84% |
3-mo | 23.29% |
6-mo | 29.05% |
1-year | 15.00% |
3-year | 16.92% |
5-year | 47.45% |
YTD | 21.77% |
2023 | 2.20% |
2022 | -42.41% |
2021 | 42.00% |
2020 | 17.32% |
2019 | 52.31% |
Continue Researching EW
Here are a few links from around the web to help you further your research on Edwards Lifesciences Corp's stock as an investment opportunity:Edwards Lifesciences Corp (EW) Stock Price | Nasdaq
Edwards Lifesciences Corp (EW) Stock Quote, History and News - Yahoo Finance
Edwards Lifesciences Corp (EW) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...